RecruitingNCT04204642
SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)
Studying Hereditary cerebral amyloid angiopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Intervention
- CAA patients data collection(other)
- Enrollment
- 500 enrolled
- Eligibility
- 55 years · All sexes
- Timeline
- 2020 – 2027
Study locations (1)
- UOC Neurologia 5, Milan, Milano, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04204642 on ClinicalTrials.govOther trials for Hereditary cerebral amyloid angiopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06714097Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGPHASE2NCT05709314A Study of AMDX-2011P in Participants With CAAAmydis Inc.
- RECRUITINGPHASE2NCT06393712A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid AngiopathyAlnylam Pharmaceuticals
- ACTIVE NOT RECRUITINGNCT06128824High Frequency Imaging in Cerebral Amyloid AngiopathyMartin Dichgans